nodes	percent_of_prediction	percent_of_DWPC	metapath
Ropivacaine—SCN10A—skin cancer	0.585	1	CbGaD
Ropivacaine—CYP1A2—Imiquimod—skin cancer	0.0616	0.224	CbGbCtD
Ropivacaine—CYP1A2—Vemurafenib—skin cancer	0.0338	0.123	CbGbCtD
Ropivacaine—CYP3A4—Imiquimod—skin cancer	0.0323	0.117	CbGbCtD
Ropivacaine—CYP3A4—Temozolomide—skin cancer	0.0323	0.117	CbGbCtD
Ropivacaine—CYP2D6—Vemurafenib—skin cancer	0.0278	0.101	CbGbCtD
Ropivacaine—CYP1A2—Dacarbazine—skin cancer	0.0259	0.0941	CbGbCtD
Ropivacaine—CYP3A4—Vismodegib—skin cancer	0.0224	0.0814	CbGbCtD
Ropivacaine—CYP3A4—Vemurafenib—skin cancer	0.0177	0.0643	CbGbCtD
Ropivacaine—CYP1A2—Fluorouracil—skin cancer	0.0152	0.0552	CbGbCtD
Ropivacaine—CYP3A4—Docetaxel—skin cancer	0.00607	0.0221	CbGbCtD
Ropivacaine—SCN8A—Interaction between L1 and Ankyrins—SCN10A—skin cancer	0.00221	0.0942	CbGpPWpGaD
Ropivacaine—SCN9A—Interaction between L1 and Ankyrins—SCN10A—skin cancer	0.00179	0.0762	CbGpPWpGaD
Ropivacaine—SCN3A—Interaction between L1 and Ankyrins—SCN10A—skin cancer	0.00171	0.0729	CbGpPWpGaD
Ropivacaine—SCN4A—Interaction between L1 and Ankyrins—SCN10A—skin cancer	0.00165	0.07	CbGpPWpGaD
Ropivacaine—SCN2A—Interaction between L1 and Ankyrins—SCN10A—skin cancer	0.00165	0.07	CbGpPWpGaD
Ropivacaine—Levobupivacaine—SCN10A—skin cancer	0.00163	0.271	CrCbGaD
Ropivacaine—SCN1A—Interaction between L1 and Ankyrins—SCN10A—skin cancer	0.00159	0.0675	CbGpPWpGaD
Ropivacaine—Mepivacaine—SCN10A—skin cancer	0.00133	0.221	CrCbGaD
Ropivacaine—Bupivacaine—SCN10A—skin cancer	0.00131	0.217	CrCbGaD
Ropivacaine—SCN5A—Interaction between L1 and Ankyrins—SCN10A—skin cancer	0.00112	0.0475	CbGpPWpGaD
Ropivacaine—Tocainide—SCN10A—skin cancer	0.00099	0.164	CrCbGaD
Ropivacaine—SCN8A—L1CAM interactions—SCN10A—skin cancer	0.00085	0.0362	CbGpPWpGaD
Ropivacaine—Lidocaine—SCN10A—skin cancer	0.000765	0.127	CrCbGaD
Ropivacaine—SCN9A—L1CAM interactions—SCN10A—skin cancer	0.000687	0.0292	CbGpPWpGaD
Ropivacaine—SCN3A—L1CAM interactions—SCN10A—skin cancer	0.000657	0.028	CbGpPWpGaD
Ropivacaine—SCN2A—L1CAM interactions—SCN10A—skin cancer	0.000632	0.0269	CbGpPWpGaD
Ropivacaine—SCN4A—L1CAM interactions—SCN10A—skin cancer	0.000632	0.0269	CbGpPWpGaD
Ropivacaine—SCN1A—L1CAM interactions—SCN10A—skin cancer	0.000609	0.0259	CbGpPWpGaD
Ropivacaine—SCN5A—L1CAM interactions—SCN10A—skin cancer	0.000428	0.0182	CbGpPWpGaD
Ropivacaine—SCN8A—Axon guidance—SCN10A—skin cancer	0.000321	0.0137	CbGpPWpGaD
Ropivacaine—Infection—Imiquimod—skin cancer	0.000261	0.00237	CcSEcCtD
Ropivacaine—SCN9A—Axon guidance—SCN10A—skin cancer	0.00026	0.0111	CbGpPWpGaD
Ropivacaine—Dysuria—Temozolomide—skin cancer	0.000259	0.00235	CcSEcCtD
Ropivacaine—Shock—Imiquimod—skin cancer	0.000259	0.00235	CcSEcCtD
Ropivacaine—Tachycardia—Imiquimod—skin cancer	0.000257	0.00233	CcSEcCtD
Ropivacaine—Skin disorder—Imiquimod—skin cancer	0.000255	0.00232	CcSEcCtD
Ropivacaine—Hyperhidrosis—Imiquimod—skin cancer	0.000254	0.00231	CcSEcCtD
Ropivacaine—Hyperglycaemia—Temozolomide—skin cancer	0.00025	0.00227	CcSEcCtD
Ropivacaine—SCN3A—Axon guidance—SCN10A—skin cancer	0.000248	0.0106	CbGpPWpGaD
Ropivacaine—Phlebitis—Docetaxel—skin cancer	0.000247	0.00225	CcSEcCtD
Ropivacaine—Depression—Temozolomide—skin cancer	0.000246	0.00224	CcSEcCtD
Ropivacaine—Blood alkaline phosphatase increased—Docetaxel—skin cancer	0.000245	0.00222	CcSEcCtD
Ropivacaine—Body temperature increased—Vemurafenib—skin cancer	0.000244	0.00221	CcSEcCtD
Ropivacaine—Neuropathy peripheral—Temozolomide—skin cancer	0.000242	0.0022	CcSEcCtD
Ropivacaine—Urinary tract infection—Temozolomide—skin cancer	0.00024	0.00218	CcSEcCtD
Ropivacaine—Musculoskeletal discomfort—Imiquimod—skin cancer	0.000239	0.00217	CcSEcCtD
Ropivacaine—SCN4A—Axon guidance—SCN10A—skin cancer	0.000239	0.0102	CbGpPWpGaD
Ropivacaine—SCN2A—Axon guidance—SCN10A—skin cancer	0.000239	0.0102	CbGpPWpGaD
Ropivacaine—Insomnia—Imiquimod—skin cancer	0.000238	0.00216	CcSEcCtD
Ropivacaine—Paraesthesia—Imiquimod—skin cancer	0.000236	0.00214	CcSEcCtD
Ropivacaine—Chills—Bleomycin—skin cancer	0.000236	0.00214	CcSEcCtD
Ropivacaine—Dyspnoea—Imiquimod—skin cancer	0.000234	0.00213	CcSEcCtD
Ropivacaine—Somnolence—Imiquimod—skin cancer	0.000234	0.00212	CcSEcCtD
Ropivacaine—Dyspepsia—Imiquimod—skin cancer	0.000231	0.0021	CcSEcCtD
Ropivacaine—SCN1A—Axon guidance—SCN10A—skin cancer	0.00023	0.00979	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—SCN10A—skin cancer	0.000229	0.00975	CbGpPWpGaD
Ropivacaine—Erythema—Bleomycin—skin cancer	0.000229	0.00208	CcSEcCtD
Ropivacaine—Hypersensitivity—Vemurafenib—skin cancer	0.000227	0.00206	CcSEcCtD
Ropivacaine—Atrial fibrillation—Docetaxel—skin cancer	0.000225	0.00204	CcSEcCtD
Ropivacaine—Pain—Imiquimod—skin cancer	0.000225	0.00204	CcSEcCtD
Ropivacaine—Acute coronary syndrome—Fluorouracil—skin cancer	0.000224	0.00204	CcSEcCtD
Ropivacaine—Neuropathy peripheral—Fluorouracil—skin cancer	0.000223	0.00202	CcSEcCtD
Ropivacaine—Myocardial infarction—Fluorouracil—skin cancer	0.000223	0.00202	CcSEcCtD
Ropivacaine—Urinary tract infection—Fluorouracil—skin cancer	0.000221	0.00201	CcSEcCtD
Ropivacaine—Asthenia—Vemurafenib—skin cancer	0.000221	0.00201	CcSEcCtD
Ropivacaine—Hallucination—Temozolomide—skin cancer	0.000221	0.002	CcSEcCtD
Ropivacaine—Hypoaesthesia—Temozolomide—skin cancer	0.000221	0.002	CcSEcCtD
Ropivacaine—Chills—Dactinomycin—skin cancer	0.00022	0.002	CcSEcCtD
Ropivacaine—Urinary tract disorder—Temozolomide—skin cancer	0.000219	0.00199	CcSEcCtD
Ropivacaine—Oedema peripheral—Temozolomide—skin cancer	0.000218	0.00198	CcSEcCtD
Ropivacaine—Pruritus—Vemurafenib—skin cancer	0.000218	0.00198	CcSEcCtD
Ropivacaine—Urethral disorder—Temozolomide—skin cancer	0.000217	0.00197	CcSEcCtD
Ropivacaine—Feeling abnormal—Imiquimod—skin cancer	0.000217	0.00197	CcSEcCtD
Ropivacaine—Gastrointestinal pain—Imiquimod—skin cancer	0.000215	0.00195	CcSEcCtD
Ropivacaine—Erythema—Dactinomycin—skin cancer	0.000213	0.00194	CcSEcCtD
Ropivacaine—Ill-defined disorder—Bleomycin—skin cancer	0.000212	0.00193	CcSEcCtD
Ropivacaine—Anaemia—Bleomycin—skin cancer	0.000211	0.00192	CcSEcCtD
Ropivacaine—Diarrhoea—Vemurafenib—skin cancer	0.000211	0.00191	CcSEcCtD
Ropivacaine—Urticaria—Imiquimod—skin cancer	0.000209	0.0019	CcSEcCtD
Ropivacaine—Abdominal pain—Imiquimod—skin cancer	0.000208	0.00189	CcSEcCtD
Ropivacaine—Body temperature increased—Imiquimod—skin cancer	0.000208	0.00189	CcSEcCtD
Ropivacaine—Tinnitus—Temozolomide—skin cancer	0.000207	0.00188	CcSEcCtD
Ropivacaine—Malaise—Bleomycin—skin cancer	0.000206	0.00187	CcSEcCtD
Ropivacaine—Cardiac disorder—Temozolomide—skin cancer	0.000206	0.00187	CcSEcCtD
Ropivacaine—Rhinitis—Fluorouracil—skin cancer	0.000205	0.00186	CcSEcCtD
Ropivacaine—Dizziness—Vemurafenib—skin cancer	0.000204	0.00185	CcSEcCtD
Ropivacaine—Hypoaesthesia—Fluorouracil—skin cancer	0.000203	0.00184	CcSEcCtD
Ropivacaine—Cough—Bleomycin—skin cancer	0.0002	0.00181	CcSEcCtD
Ropivacaine—Chills—Temozolomide—skin cancer	0.000199	0.00181	CcSEcCtD
Ropivacaine—Ill-defined disorder—Dactinomycin—skin cancer	0.000198	0.0018	CcSEcCtD
Ropivacaine—Anaemia—Dactinomycin—skin cancer	0.000197	0.00179	CcSEcCtD
Ropivacaine—Vomiting—Vemurafenib—skin cancer	0.000196	0.00178	CcSEcCtD
Ropivacaine—Myalgia—Bleomycin—skin cancer	0.000195	0.00177	CcSEcCtD
Ropivacaine—Chest pain—Bleomycin—skin cancer	0.000195	0.00177	CcSEcCtD
Ropivacaine—Orthostatic hypotension—Docetaxel—skin cancer	0.000195	0.00177	CcSEcCtD
Ropivacaine—Rash—Vemurafenib—skin cancer	0.000194	0.00176	CcSEcCtD
Ropivacaine—Mental disorder—Temozolomide—skin cancer	0.000194	0.00176	CcSEcCtD
Ropivacaine—Dermatitis—Vemurafenib—skin cancer	0.000194	0.00176	CcSEcCtD
Ropivacaine—Hypersensitivity—Imiquimod—skin cancer	0.000194	0.00176	CcSEcCtD
Ropivacaine—Headache—Vemurafenib—skin cancer	0.000193	0.00175	CcSEcCtD
Ropivacaine—Erythema—Temozolomide—skin cancer	0.000193	0.00175	CcSEcCtD
Ropivacaine—Breast disorder—Docetaxel—skin cancer	0.000193	0.00175	CcSEcCtD
Ropivacaine—Discomfort—Bleomycin—skin cancer	0.000192	0.00175	CcSEcCtD
Ropivacaine—Malaise—Dactinomycin—skin cancer	0.000192	0.00175	CcSEcCtD
Ropivacaine—Aspartate aminotransferase increased—Docetaxel—skin cancer	0.000192	0.00174	CcSEcCtD
Ropivacaine—Cramp muscle—Docetaxel—skin cancer	0.000192	0.00174	CcSEcCtD
Ropivacaine—Asthenia—Imiquimod—skin cancer	0.000189	0.00171	CcSEcCtD
Ropivacaine—Confusional state—Bleomycin—skin cancer	0.000188	0.00171	CcSEcCtD
Ropivacaine—Alanine aminotransferase increased—Docetaxel—skin cancer	0.000188	0.00171	CcSEcCtD
Ropivacaine—Anaphylactic shock—Bleomycin—skin cancer	0.000187	0.00169	CcSEcCtD
Ropivacaine—Back pain—Temozolomide—skin cancer	0.000187	0.00169	CcSEcCtD
Ropivacaine—Pruritus—Imiquimod—skin cancer	0.000186	0.00169	CcSEcCtD
Ropivacaine—Infection—Bleomycin—skin cancer	0.000186	0.00168	CcSEcCtD
Ropivacaine—SCN9A—Developmental Biology—SCN10A—skin cancer	0.000185	0.00789	CbGpPWpGaD
Ropivacaine—SCN8A—Axon guidance—RASA1—skin cancer	0.000184	0.00785	CbGpPWpGaD
Ropivacaine—Nausea—Vemurafenib—skin cancer	0.000183	0.00166	CcSEcCtD
Ropivacaine—Thrombocytopenia—Bleomycin—skin cancer	0.000183	0.00166	CcSEcCtD
Ropivacaine—Arrhythmia—Fluorouracil—skin cancer	0.000182	0.00166	CcSEcCtD
Ropivacaine—Vision blurred—Temozolomide—skin cancer	0.000182	0.00165	CcSEcCtD
Ropivacaine—Myalgia—Dactinomycin—skin cancer	0.000182	0.00165	CcSEcCtD
Ropivacaine—Bronchospasm—Docetaxel—skin cancer	0.000181	0.00164	CcSEcCtD
Ropivacaine—Tremor—Temozolomide—skin cancer	0.000181	0.00164	CcSEcCtD
Ropivacaine—Diarrhoea—Imiquimod—skin cancer	0.00018	0.00163	CcSEcCtD
Ropivacaine—Discomfort—Dactinomycin—skin cancer	0.000179	0.00163	CcSEcCtD
Ropivacaine—Ill-defined disorder—Temozolomide—skin cancer	0.000179	0.00163	CcSEcCtD
Ropivacaine—Anaemia—Temozolomide—skin cancer	0.000178	0.00162	CcSEcCtD
Ropivacaine—Erythema—Fluorouracil—skin cancer	0.000178	0.00161	CcSEcCtD
Ropivacaine—Agitation—Temozolomide—skin cancer	0.000177	0.00161	CcSEcCtD
Ropivacaine—SCN3A—Developmental Biology—SCN10A—skin cancer	0.000177	0.00754	CbGpPWpGaD
Ropivacaine—Angioedema—Temozolomide—skin cancer	0.000176	0.0016	CcSEcCtD
Ropivacaine—Hypotension—Bleomycin—skin cancer	0.000174	0.00158	CcSEcCtD
Ropivacaine—Malaise—Temozolomide—skin cancer	0.000174	0.00158	CcSEcCtD
Ropivacaine—Dizziness—Imiquimod—skin cancer	0.000174	0.00158	CcSEcCtD
Ropivacaine—Vertigo—Temozolomide—skin cancer	0.000173	0.00157	CcSEcCtD
Ropivacaine—Infection—Dactinomycin—skin cancer	0.000173	0.00157	CcSEcCtD
Ropivacaine—Thrombocytopenia—Dactinomycin—skin cancer	0.000171	0.00155	CcSEcCtD
Ropivacaine—SCN4A—Developmental Biology—SCN10A—skin cancer	0.00017	0.00725	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—SCN10A—skin cancer	0.00017	0.00725	CbGpPWpGaD
Ropivacaine—Musculoskeletal discomfort—Bleomycin—skin cancer	0.00017	0.00154	CcSEcCtD
Ropivacaine—Cough—Temozolomide—skin cancer	0.000168	0.00153	CcSEcCtD
Ropivacaine—Paraesthesia—Bleomycin—skin cancer	0.000168	0.00152	CcSEcCtD
Ropivacaine—Vision blurred—Fluorouracil—skin cancer	0.000168	0.00152	CcSEcCtD
Ropivacaine—Convulsion—Temozolomide—skin cancer	0.000167	0.00152	CcSEcCtD
Ropivacaine—Vomiting—Imiquimod—skin cancer	0.000167	0.00152	CcSEcCtD
Ropivacaine—Hypertension—Temozolomide—skin cancer	0.000167	0.00151	CcSEcCtD
Ropivacaine—Dyspnoea—Bleomycin—skin cancer	0.000166	0.00151	CcSEcCtD
Ropivacaine—Rash—Imiquimod—skin cancer	0.000166	0.0015	CcSEcCtD
Ropivacaine—Dermatitis—Imiquimod—skin cancer	0.000166	0.0015	CcSEcCtD
Ropivacaine—Headache—Imiquimod—skin cancer	0.000165	0.00149	CcSEcCtD
Ropivacaine—Anaemia—Fluorouracil—skin cancer	0.000164	0.00149	CcSEcCtD
Ropivacaine—Myalgia—Temozolomide—skin cancer	0.000164	0.00149	CcSEcCtD
Ropivacaine—Arthralgia—Temozolomide—skin cancer	0.000164	0.00149	CcSEcCtD
Ropivacaine—SCN1A—Developmental Biology—SCN10A—skin cancer	0.000164	0.00699	CbGpPWpGaD
Ropivacaine—Anxiety—Temozolomide—skin cancer	0.000164	0.00149	CcSEcCtD
Ropivacaine—Discomfort—Temozolomide—skin cancer	0.000162	0.00147	CcSEcCtD
Ropivacaine—Acute coronary syndrome—Docetaxel—skin cancer	0.000162	0.00147	CcSEcCtD
Ropivacaine—SCN5A—Axon guidance—SCN10A—skin cancer	0.000162	0.00688	CbGpPWpGaD
Ropivacaine—Myocardial infarction—Docetaxel—skin cancer	0.000161	0.00146	CcSEcCtD
Ropivacaine—Neuropathy peripheral—Docetaxel—skin cancer	0.000161	0.00146	CcSEcCtD
Ropivacaine—Jaundice—Docetaxel—skin cancer	0.00016	0.00145	CcSEcCtD
Ropivacaine—Pain—Bleomycin—skin cancer	0.00016	0.00145	CcSEcCtD
Ropivacaine—Confusional state—Temozolomide—skin cancer	0.000159	0.00144	CcSEcCtD
Ropivacaine—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000159	0.00144	CcSEcCtD
Ropivacaine—Anaphylactic shock—Temozolomide—skin cancer	0.000158	0.00143	CcSEcCtD
Ropivacaine—Infection—Temozolomide—skin cancer	0.000156	0.00142	CcSEcCtD
Ropivacaine—Nausea—Imiquimod—skin cancer	0.000156	0.00142	CcSEcCtD
Ropivacaine—Thrombocytopenia—Temozolomide—skin cancer	0.000154	0.0014	CcSEcCtD
Ropivacaine—Convulsion—Fluorouracil—skin cancer	0.000154	0.0014	CcSEcCtD
Ropivacaine—Feeling abnormal—Bleomycin—skin cancer	0.000154	0.0014	CcSEcCtD
Ropivacaine—Skin disorder—Temozolomide—skin cancer	0.000153	0.00139	CcSEcCtD
Ropivacaine—Hyperhidrosis—Temozolomide—skin cancer	0.000152	0.00138	CcSEcCtD
Ropivacaine—Myalgia—Fluorouracil—skin cancer	0.000151	0.00137	CcSEcCtD
Ropivacaine—Chest pain—Fluorouracil—skin cancer	0.000151	0.00137	CcSEcCtD
Ropivacaine—Discomfort—Fluorouracil—skin cancer	0.00015	0.00136	CcSEcCtD
Ropivacaine—SCN9A—Axon guidance—RASA1—skin cancer	0.000149	0.00635	CbGpPWpGaD
Ropivacaine—Pain—Dactinomycin—skin cancer	0.000149	0.00135	CcSEcCtD
Ropivacaine—Urticaria—Bleomycin—skin cancer	0.000148	0.00135	CcSEcCtD
Ropivacaine—Rhinitis—Docetaxel—skin cancer	0.000148	0.00134	CcSEcCtD
Ropivacaine—Body temperature increased—Bleomycin—skin cancer	0.000148	0.00134	CcSEcCtD
Ropivacaine—Hypoaesthesia—Docetaxel—skin cancer	0.000147	0.00133	CcSEcCtD
Ropivacaine—Confusional state—Fluorouracil—skin cancer	0.000146	0.00133	CcSEcCtD
Ropivacaine—Urinary tract disorder—Docetaxel—skin cancer	0.000146	0.00132	CcSEcCtD
Ropivacaine—Oedema peripheral—Docetaxel—skin cancer	0.000145	0.00132	CcSEcCtD
Ropivacaine—Anaphylactic shock—Fluorouracil—skin cancer	0.000145	0.00132	CcSEcCtD
Ropivacaine—Urethral disorder—Docetaxel—skin cancer	0.000145	0.00131	CcSEcCtD
Ropivacaine—Infection—Fluorouracil—skin cancer	0.000144	0.00131	CcSEcCtD
Ropivacaine—Feeling abnormal—Dactinomycin—skin cancer	0.000144	0.0013	CcSEcCtD
Ropivacaine—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000144	0.0013	CcSEcCtD
Ropivacaine—SCN3A—Axon guidance—RASA1—skin cancer	0.000143	0.00607	CbGpPWpGaD
Ropivacaine—Insomnia—Temozolomide—skin cancer	0.000142	0.00129	CcSEcCtD
Ropivacaine—Gastrointestinal pain—Dactinomycin—skin cancer	0.000142	0.00129	CcSEcCtD
Ropivacaine—Thrombocytopenia—Fluorouracil—skin cancer	0.000142	0.00129	CcSEcCtD
Ropivacaine—Tachycardia—Fluorouracil—skin cancer	0.000142	0.00129	CcSEcCtD
Ropivacaine—Paraesthesia—Temozolomide—skin cancer	0.000141	0.00128	CcSEcCtD
Ropivacaine—Dyspnoea—Temozolomide—skin cancer	0.00014	0.00127	CcSEcCtD
Ropivacaine—Somnolence—Temozolomide—skin cancer	0.00014	0.00127	CcSEcCtD
Ropivacaine—Dyspepsia—Temozolomide—skin cancer	0.000139	0.00126	CcSEcCtD
Ropivacaine—Abdominal pain—Dactinomycin—skin cancer	0.000138	0.00125	CcSEcCtD
Ropivacaine—Body temperature increased—Dactinomycin—skin cancer	0.000138	0.00125	CcSEcCtD
Ropivacaine—Hypersensitivity—Bleomycin—skin cancer	0.000138	0.00125	CcSEcCtD
Ropivacaine—SCN2A—Axon guidance—RASA1—skin cancer	0.000137	0.00583	CbGpPWpGaD
Ropivacaine—SCN4A—Axon guidance—RASA1—skin cancer	0.000137	0.00583	CbGpPWpGaD
Ropivacaine—Cardiac disorder—Docetaxel—skin cancer	0.000137	0.00124	CcSEcCtD
Ropivacaine—Hypotension—Fluorouracil—skin cancer	0.000136	0.00123	CcSEcCtD
Ropivacaine—Pain—Temozolomide—skin cancer	0.000135	0.00122	CcSEcCtD
Ropivacaine—Constipation—Temozolomide—skin cancer	0.000135	0.00122	CcSEcCtD
Ropivacaine—Asthenia—Bleomycin—skin cancer	0.000134	0.00122	CcSEcCtD
Ropivacaine—Chills—Docetaxel—skin cancer	0.000132	0.0012	CcSEcCtD
Ropivacaine—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000132	0.0012	CcSEcCtD
Ropivacaine—SCN10A—Axon guidance—RASA1—skin cancer	0.000132	0.00562	CbGpPWpGaD
Ropivacaine—SCN1A—Axon guidance—RASA1—skin cancer	0.000132	0.00562	CbGpPWpGaD
Ropivacaine—Pruritus—Bleomycin—skin cancer	0.000132	0.0012	CcSEcCtD
Ropivacaine—Arrhythmia—Docetaxel—skin cancer	0.000132	0.0012	CcSEcCtD
Ropivacaine—SCN8A—Developmental Biology—RASA1—skin cancer	0.000132	0.0056	CbGpPWpGaD
Ropivacaine—Insomnia—Fluorouracil—skin cancer	0.000131	0.00119	CcSEcCtD
Ropivacaine—Paraesthesia—Fluorouracil—skin cancer	0.00013	0.00118	CcSEcCtD
Ropivacaine—Feeling abnormal—Temozolomide—skin cancer	0.00013	0.00118	CcSEcCtD
Ropivacaine—Dyspnoea—Fluorouracil—skin cancer	0.000129	0.00117	CcSEcCtD
Ropivacaine—Mental disorder—Docetaxel—skin cancer	0.000129	0.00117	CcSEcCtD
Ropivacaine—Somnolence—Fluorouracil—skin cancer	0.000129	0.00117	CcSEcCtD
Ropivacaine—Gastrointestinal pain—Temozolomide—skin cancer	0.000129	0.00117	CcSEcCtD
Ropivacaine—Erythema—Docetaxel—skin cancer	0.000128	0.00116	CcSEcCtD
Ropivacaine—Hypersensitivity—Dactinomycin—skin cancer	0.000128	0.00116	CcSEcCtD
Ropivacaine—Dyspepsia—Fluorouracil—skin cancer	0.000128	0.00116	CcSEcCtD
Ropivacaine—Urticaria—Temozolomide—skin cancer	0.000125	0.00114	CcSEcCtD
Ropivacaine—Asthenia—Dactinomycin—skin cancer	0.000125	0.00113	CcSEcCtD
Ropivacaine—Abdominal pain—Temozolomide—skin cancer	0.000125	0.00113	CcSEcCtD
Ropivacaine—Body temperature increased—Temozolomide—skin cancer	0.000125	0.00113	CcSEcCtD
Ropivacaine—Back pain—Docetaxel—skin cancer	0.000124	0.00113	CcSEcCtD
Ropivacaine—Pain—Fluorouracil—skin cancer	0.000124	0.00113	CcSEcCtD
Ropivacaine—Muscle spasms—Docetaxel—skin cancer	0.000123	0.00112	CcSEcCtD
Ropivacaine—Feeling abnormal—Fluorouracil—skin cancer	0.00012	0.00109	CcSEcCtD
Ropivacaine—Diarrhoea—Dactinomycin—skin cancer	0.000119	0.00108	CcSEcCtD
Ropivacaine—Vomiting—Bleomycin—skin cancer	0.000119	0.00108	CcSEcCtD
Ropivacaine—Anaemia—Docetaxel—skin cancer	0.000119	0.00108	CcSEcCtD
Ropivacaine—Rash—Bleomycin—skin cancer	0.000118	0.00107	CcSEcCtD
Ropivacaine—Dermatitis—Bleomycin—skin cancer	0.000118	0.00107	CcSEcCtD
Ropivacaine—Hypersensitivity—Temozolomide—skin cancer	0.000116	0.00105	CcSEcCtD
Ropivacaine—SCN5A—Developmental Biology—SCN10A—skin cancer	0.000115	0.00491	CbGpPWpGaD
Ropivacaine—Urticaria—Fluorouracil—skin cancer	0.000115	0.00105	CcSEcCtD
Ropivacaine—Syncope—Docetaxel—skin cancer	0.000115	0.00104	CcSEcCtD
Ropivacaine—Body temperature increased—Fluorouracil—skin cancer	0.000115	0.00104	CcSEcCtD
Ropivacaine—Asthenia—Temozolomide—skin cancer	0.000113	0.00103	CcSEcCtD
Ropivacaine—Loss of consciousness—Docetaxel—skin cancer	0.000113	0.00102	CcSEcCtD
Ropivacaine—Cough—Docetaxel—skin cancer	0.000112	0.00102	CcSEcCtD
Ropivacaine—Pruritus—Temozolomide—skin cancer	0.000111	0.00101	CcSEcCtD
Ropivacaine—Convulsion—Docetaxel—skin cancer	0.000111	0.00101	CcSEcCtD
Ropivacaine—Nausea—Bleomycin—skin cancer	0.000111	0.00101	CcSEcCtD
Ropivacaine—Hypertension—Docetaxel—skin cancer	0.000111	0.00101	CcSEcCtD
Ropivacaine—Vomiting—Dactinomycin—skin cancer	0.000111	0.001	CcSEcCtD
Ropivacaine—Rash—Dactinomycin—skin cancer	0.00011	0.000997	CcSEcCtD
Ropivacaine—Arthralgia—Docetaxel—skin cancer	0.000109	0.000992	CcSEcCtD
Ropivacaine—Myalgia—Docetaxel—skin cancer	0.000109	0.000992	CcSEcCtD
Ropivacaine—Chest pain—Docetaxel—skin cancer	0.000109	0.000992	CcSEcCtD
Ropivacaine—Diarrhoea—Temozolomide—skin cancer	0.000108	0.000978	CcSEcCtD
Ropivacaine—Hypersensitivity—Fluorouracil—skin cancer	0.000107	0.00097	CcSEcCtD
Ropivacaine—SCN9A—Developmental Biology—RASA1—skin cancer	0.000106	0.00453	CbGpPWpGaD
Ropivacaine—Confusional state—Docetaxel—skin cancer	0.000106	0.000959	CcSEcCtD
Ropivacaine—Anaphylactic shock—Docetaxel—skin cancer	0.000105	0.000951	CcSEcCtD
Ropivacaine—Dizziness—Temozolomide—skin cancer	0.000104	0.000945	CcSEcCtD
Ropivacaine—Infection—Docetaxel—skin cancer	0.000104	0.000945	CcSEcCtD
Ropivacaine—Nausea—Dactinomycin—skin cancer	0.000103	0.000939	CcSEcCtD
Ropivacaine—Shock—Docetaxel—skin cancer	0.000103	0.000935	CcSEcCtD
Ropivacaine—Pruritus—Fluorouracil—skin cancer	0.000103	0.000932	CcSEcCtD
Ropivacaine—Thrombocytopenia—Docetaxel—skin cancer	0.000103	0.000931	CcSEcCtD
Ropivacaine—Tachycardia—Docetaxel—skin cancer	0.000102	0.000928	CcSEcCtD
Ropivacaine—SCN3A—Developmental Biology—RASA1—skin cancer	0.000102	0.00433	CbGpPWpGaD
Ropivacaine—Skin disorder—Docetaxel—skin cancer	0.000102	0.000923	CcSEcCtD
Ropivacaine—Vomiting—Temozolomide—skin cancer	0.0001	0.000909	CcSEcCtD
Ropivacaine—Rash—Temozolomide—skin cancer	9.93e-05	0.000901	CcSEcCtD
Ropivacaine—Diarrhoea—Fluorouracil—skin cancer	9.93e-05	0.000901	CcSEcCtD
Ropivacaine—Dermatitis—Temozolomide—skin cancer	9.92e-05	0.000901	CcSEcCtD
Ropivacaine—Headache—Temozolomide—skin cancer	9.87e-05	0.000896	CcSEcCtD
Ropivacaine—Hypotension—Docetaxel—skin cancer	9.79e-05	0.000888	CcSEcCtD
Ropivacaine—SCN4A—Developmental Biology—RASA1—skin cancer	9.78e-05	0.00416	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—RASA1—skin cancer	9.78e-05	0.00416	CbGpPWpGaD
Ropivacaine—Dizziness—Fluorouracil—skin cancer	9.6e-05	0.000871	CcSEcCtD
Ropivacaine—Musculoskeletal discomfort—Docetaxel—skin cancer	9.54e-05	0.000866	CcSEcCtD
Ropivacaine—Insomnia—Docetaxel—skin cancer	9.47e-05	0.00086	CcSEcCtD
Ropivacaine—SCN1A—Developmental Biology—RASA1—skin cancer	9.43e-05	0.00401	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—RASA1—skin cancer	9.43e-05	0.00401	CbGpPWpGaD
Ropivacaine—Paraesthesia—Docetaxel—skin cancer	9.41e-05	0.000854	CcSEcCtD
Ropivacaine—Nausea—Temozolomide—skin cancer	9.36e-05	0.000849	CcSEcCtD
Ropivacaine—Dyspnoea—Docetaxel—skin cancer	9.34e-05	0.000848	CcSEcCtD
Ropivacaine—Somnolence—Docetaxel—skin cancer	9.31e-05	0.000845	CcSEcCtD
Ropivacaine—SCN5A—Axon guidance—RASA1—skin cancer	9.29e-05	0.00395	CbGpPWpGaD
Ropivacaine—Vomiting—Fluorouracil—skin cancer	9.23e-05	0.000838	CcSEcCtD
Ropivacaine—Dyspepsia—Docetaxel—skin cancer	9.22e-05	0.000837	CcSEcCtD
Ropivacaine—Rash—Fluorouracil—skin cancer	9.15e-05	0.000831	CcSEcCtD
Ropivacaine—Dermatitis—Fluorouracil—skin cancer	9.14e-05	0.00083	CcSEcCtD
Ropivacaine—Headache—Fluorouracil—skin cancer	9.09e-05	0.000825	CcSEcCtD
Ropivacaine—Pain—Docetaxel—skin cancer	8.96e-05	0.000813	CcSEcCtD
Ropivacaine—Constipation—Docetaxel—skin cancer	8.96e-05	0.000813	CcSEcCtD
Ropivacaine—Feeling abnormal—Docetaxel—skin cancer	8.63e-05	0.000783	CcSEcCtD
Ropivacaine—Nausea—Fluorouracil—skin cancer	8.62e-05	0.000782	CcSEcCtD
Ropivacaine—Gastrointestinal pain—Docetaxel—skin cancer	8.57e-05	0.000777	CcSEcCtD
Ropivacaine—Body temperature increased—Docetaxel—skin cancer	8.28e-05	0.000752	CcSEcCtD
Ropivacaine—Abdominal pain—Docetaxel—skin cancer	8.28e-05	0.000752	CcSEcCtD
Ropivacaine—Hypersensitivity—Docetaxel—skin cancer	7.72e-05	0.0007	CcSEcCtD
Ropivacaine—Asthenia—Docetaxel—skin cancer	7.52e-05	0.000682	CcSEcCtD
Ropivacaine—Pruritus—Docetaxel—skin cancer	7.41e-05	0.000673	CcSEcCtD
Ropivacaine—Diarrhoea—Docetaxel—skin cancer	7.17e-05	0.00065	CcSEcCtD
Ropivacaine—Dizziness—Docetaxel—skin cancer	6.93e-05	0.000629	CcSEcCtD
Ropivacaine—Vomiting—Docetaxel—skin cancer	6.66e-05	0.000604	CcSEcCtD
Ropivacaine—SCN5A—Developmental Biology—RASA1—skin cancer	6.63e-05	0.00282	CbGpPWpGaD
Ropivacaine—Rash—Docetaxel—skin cancer	6.6e-05	0.000599	CcSEcCtD
Ropivacaine—Dermatitis—Docetaxel—skin cancer	6.6e-05	0.000599	CcSEcCtD
Ropivacaine—Headache—Docetaxel—skin cancer	6.56e-05	0.000596	CcSEcCtD
Ropivacaine—SCN8A—Developmental Biology—CDK4—skin cancer	6.46e-05	0.00275	CbGpPWpGaD
Ropivacaine—Nausea—Docetaxel—skin cancer	6.22e-05	0.000565	CcSEcCtD
Ropivacaine—SCN9A—Developmental Biology—CDK4—skin cancer	5.22e-05	0.00222	CbGpPWpGaD
Ropivacaine—SCN8A—Axon guidance—NRAS—skin cancer	5.03e-05	0.00214	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—CDK4—skin cancer	4.99e-05	0.00212	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—CDK4—skin cancer	4.8e-05	0.00204	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—CDK4—skin cancer	4.8e-05	0.00204	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—CDK4—skin cancer	4.63e-05	0.00197	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—CDK4—skin cancer	4.63e-05	0.00197	CbGpPWpGaD
Ropivacaine—SCN8A—Axon guidance—KRAS—skin cancer	4.33e-05	0.00184	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—skin cancer	4.1e-05	0.00174	CbGpPWpGaD
Ropivacaine—SCN9A—Axon guidance—NRAS—skin cancer	4.07e-05	0.00173	CbGpPWpGaD
Ropivacaine—SCN3A—Axon guidance—NRAS—skin cancer	3.89e-05	0.00166	CbGpPWpGaD
Ropivacaine—CYP1A2—Arachidonic acid metabolism—PTGS2—skin cancer	3.83e-05	0.00163	CbGpPWpGaD
Ropivacaine—SCN2A—Axon guidance—NRAS—skin cancer	3.74e-05	0.00159	CbGpPWpGaD
Ropivacaine—SCN4A—Axon guidance—NRAS—skin cancer	3.74e-05	0.00159	CbGpPWpGaD
Ropivacaine—SCN8A—Axon guidance—HRAS—skin cancer	3.68e-05	0.00157	CbGpPWpGaD
Ropivacaine—SCN1A—Axon guidance—NRAS—skin cancer	3.61e-05	0.00153	CbGpPWpGaD
Ropivacaine—SCN10A—Axon guidance—NRAS—skin cancer	3.61e-05	0.00153	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—NRAS—skin cancer	3.59e-05	0.00153	CbGpPWpGaD
Ropivacaine—SCN8A—Axon guidance—IL6—skin cancer	3.52e-05	0.0015	CbGpPWpGaD
Ropivacaine—SCN9A—Axon guidance—KRAS—skin cancer	3.5e-05	0.00149	CbGpPWpGaD
Ropivacaine—SCN3A—Axon guidance—KRAS—skin cancer	3.35e-05	0.00142	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—CDK4—skin cancer	3.25e-05	0.00138	CbGpPWpGaD
Ropivacaine—SCN2A—Axon guidance—KRAS—skin cancer	3.22e-05	0.00137	CbGpPWpGaD
Ropivacaine—SCN4A—Axon guidance—KRAS—skin cancer	3.22e-05	0.00137	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—skin cancer	3.19e-05	0.00136	CbGpPWpGaD
Ropivacaine—SCN5A—SIDS Susceptibility Pathways—IL6—skin cancer	3.18e-05	0.00135	CbGpPWpGaD
Ropivacaine—SCN10A—Axon guidance—KRAS—skin cancer	3.1e-05	0.00132	CbGpPWpGaD
Ropivacaine—SCN1A—Axon guidance—KRAS—skin cancer	3.1e-05	0.00132	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—KRAS—skin cancer	3.09e-05	0.00131	CbGpPWpGaD
Ropivacaine—SCN9A—Axon guidance—HRAS—skin cancer	2.98e-05	0.00127	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—NRAS—skin cancer	2.9e-05	0.00124	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	2.87e-05	0.00122	CbGpPWpGaD
Ropivacaine—SCN9A—Axon guidance—IL6—skin cancer	2.85e-05	0.00121	CbGpPWpGaD
Ropivacaine—SCN3A—Axon guidance—HRAS—skin cancer	2.85e-05	0.00121	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—NRAS—skin cancer	2.78e-05	0.00118	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—skin cancer	2.74e-05	0.00117	CbGpPWpGaD
Ropivacaine—SCN4A—Axon guidance—HRAS—skin cancer	2.74e-05	0.00116	CbGpPWpGaD
Ropivacaine—SCN2A—Axon guidance—HRAS—skin cancer	2.74e-05	0.00116	CbGpPWpGaD
Ropivacaine—SCN3A—Axon guidance—IL6—skin cancer	2.72e-05	0.00116	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—NRAS—skin cancer	2.67e-05	0.00113	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—NRAS—skin cancer	2.67e-05	0.00113	CbGpPWpGaD
Ropivacaine—SCN10A—Axon guidance—HRAS—skin cancer	2.64e-05	0.00112	CbGpPWpGaD
Ropivacaine—SCN1A—Axon guidance—HRAS—skin cancer	2.64e-05	0.00112	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—HRAS—skin cancer	2.63e-05	0.00112	CbGpPWpGaD
Ropivacaine—SCN2A—Axon guidance—IL6—skin cancer	2.62e-05	0.00111	CbGpPWpGaD
Ropivacaine—SCN4A—Axon guidance—IL6—skin cancer	2.62e-05	0.00111	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—NRAS—skin cancer	2.57e-05	0.00109	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—NRAS—skin cancer	2.57e-05	0.00109	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—NRAS—skin cancer	2.53e-05	0.00108	CbGpPWpGaD
Ropivacaine—SCN1A—Axon guidance—IL6—skin cancer	2.52e-05	0.00107	CbGpPWpGaD
Ropivacaine—SCN10A—Axon guidance—IL6—skin cancer	2.52e-05	0.00107	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—IL6—skin cancer	2.51e-05	0.00107	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—KRAS—skin cancer	2.5e-05	0.00106	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—KRAS—skin cancer	2.39e-05	0.00102	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—skin cancer	2.33e-05	0.000992	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—KRAS—skin cancer	2.3e-05	0.000977	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—KRAS—skin cancer	2.3e-05	0.000977	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—KRAS—skin cancer	2.21e-05	0.000942	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—KRAS—skin cancer	2.21e-05	0.000942	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—KRAS—skin cancer	2.18e-05	0.000928	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—PLIN2—skin cancer	2.17e-05	0.000923	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—HRAS—skin cancer	2.12e-05	0.000904	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—IL6—skin cancer	2.03e-05	0.000865	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—HRAS—skin cancer	2.03e-05	0.000864	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—HRAS—skin cancer	1.95e-05	0.00083	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—HRAS—skin cancer	1.95e-05	0.00083	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—IL6—skin cancer	1.94e-05	0.000827	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—HRAS—skin cancer	1.88e-05	0.000801	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—HRAS—skin cancer	1.88e-05	0.000801	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—IL6—skin cancer	1.87e-05	0.000795	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—IL6—skin cancer	1.87e-05	0.000795	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—HRAS—skin cancer	1.85e-05	0.000789	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—NRAS—skin cancer	1.81e-05	0.000769	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—IL6—skin cancer	1.8e-05	0.000766	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—IL6—skin cancer	1.8e-05	0.000766	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—IL6—skin cancer	1.77e-05	0.000755	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—CSPG4—skin cancer	1.75e-05	0.000744	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—KRAS—skin cancer	1.56e-05	0.000662	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—PLIN2—skin cancer	1.51e-05	0.000642	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—HRAS—skin cancer	1.32e-05	0.000563	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—PLIN2—skin cancer	1.28e-05	0.000544	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—IL6—skin cancer	1.27e-05	0.000539	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—CSPG4—skin cancer	1.22e-05	0.000517	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—ENO2—skin cancer	1.19e-05	0.000506	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—CSPG4—skin cancer	1.03e-05	0.000438	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—PLIN2—skin cancer	9.86e-06	0.00042	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—ENO2—skin cancer	8.27e-06	0.000352	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—CSPG4—skin cancer	7.95e-06	0.000338	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—ENO2—skin cancer	7e-06	0.000298	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—ERCC2—skin cancer	6.91e-06	0.000294	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	5.48e-06	0.000233	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—ENO2—skin cancer	5.41e-06	0.00023	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—ERCC2—skin cancer	4.8e-06	0.000204	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—PTGS2—skin cancer	4.14e-06	0.000176	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—ERCC2—skin cancer	4.07e-06	0.000173	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—ERCC2—skin cancer	3.14e-06	0.000134	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—PTGS2—skin cancer	2.88e-06	0.000122	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—PTGS2—skin cancer	2.44e-06	0.000104	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—PTGS2—skin cancer	1.88e-06	8.01e-05	CbGpPWpGaD
